Flemming Ornskov is the founder of Galderma. Latest round: IPO. Flemming Ørnskov, M.D., is the CEO of Galderma, a Swiss pharmaceutical company.
Flemming Ørnskov, M.D., is the CEO of Galderma, a Swiss pharmaceutical company. He led the company through its transition from private institutional ownership to its initial public offering in 2024, focusing on market outperformance and margin expansion.
Full founder directory · Investor directory · Company funding database · Fundraising library